AMYPCA
LIVE
Serial Number
79325843
Owner
DAIKEN MEDICAL CO., LTD.Attorney
Sean P. McMahonFiling Date
Sep 22, 2021
AMYPCA Trademark
Serial Number: 79325843 • Registration: 6891490
AMYPCA is a trademark filed by
DAIKEN MEDICAL CO., LTD.
on September 22, 2021. The trademark is classified under Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Sean P. McMahon Sean P. McMahon, PLLC
209 Garth Road 1I
Scarsdale
NY 10583
UNITED STATES
Trademark Details
Filing Date
September 22, 2021
Registration Date
November 8, 2022
Published for Opposition
August 23, 2022
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 29, 2023 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Mar 8, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 8, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 8, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 8, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 8, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Aug 23, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 23, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 23, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 3, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 3, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 3, 2022 NONP
REFUSAL PROCESSED BY IB
Jul 26, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 7, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 7, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 6, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jul 5, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 18, 2021 REPR
